The CTN
The CTN (CTN+) is the CIHR-funded Pan-Canadian Network for HIV and STBBI Clinical Trials Research, founded in 1990 and headquartered in Montreal, coordinating investigator-initiated clinical trials and training across five Canadian regions.
- Company typePrivate
- Founded1990
- HeadquartersVancouver, Canada
- Headcount101–250
- GTM typeB2B
- OfferingServices
What The CTN does
The CTN (CTN+) is the Canadian Institutes of Health Research (CIHR) Pan-Canadian Network for HIV and Sexually Transmitted and Blood-Borne Infection (STBBI) Clinical Trials Research, founded in 1990 and headquartered in Montreal at the McGill University Health Centre (MUHC). It functions as the federally designated coordinating body for HIV and STBBI clinical trials research across Canada, organizing investigators, clinical sites, community members, and trainees into a single national research infrastructure. Under its Phase 2 mandate (commenced 2025), the network has broadened its scope from HIV to the full STBBI portfolio and structured its work around four thematic Think Tanks — Prevention & Testing, Treatment & Management, Cure & Immunotherapies, and Methods — supported by five regional teams covering British Columbia & Yukon, the Prairies, Ontario, Quebec, and Atlantic Canada.
The network's core deliverables are clinical trials and translational research outputs, supported by a set of platform assets including a Knowledge Mobilization Hub, a Resource Library, a Research Toolbox, and a Featured Studies platform hosted on its website. It also runs a postdoctoral fellowship program (CTN-Postdoc) that feeds trained investigators back into the network. Operations are anchored at the MUHC and rely on affiliated investigators across more than 40 clinical sites nationally. CTN does not sell products or services; its outputs are scientific knowledge, clinical evidence, and trained researchers, distributed through publications, knowledge-translation activities, and community engagement with people living with HIV and key populations.
The CTN's business model is non-commercial: it is funded almost exclusively through peer-reviewed grants from the Canadian Institutes of Health Research, principally the Institute of Infection and Immunity, with Phase 2 funding secured in 2025. There is no disclosed product pricing, customer revenue, or commercial sponsorship model. The organization is a public-good research network whose financial sustainability is tied to ongoing federal research-funding cycles and renewal of its national network designation rather than to market-driven revenue.
The CTN firmographics
Firmographics- Name
- The CTN
- Legal name
- CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research
- Website
- https://hivnet.ubc.ca
- Company type
- Private
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- The CTN (CTN+) is the CIHR-funded Pan-Canadian Network for HIV and STBBI Clinical Trials Research, founded in 1990 and headquartered in Montreal, coordinating investigator-initiated clinical trials and training across five Canadian regions.
- Ownership category
- akta.pro rank
The CTN industry classification
Industry- Product category
- Clinical Research
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Management Systems (CTMS) (HLACAOAD)
Keywords
Where The CTN is headquartered
LocationHeadquarters
- HQ city
- Vancouver
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
The CTN business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- CIHR Government Funding: CTN+ receives funding from the Canadian Institutes of Health Research (CIHR) Institute of Infection & Immunity. The network successfully secured Phase 2 grants from CIHR, with the Phase 2 initiative aimed at strengthening Canada's capacity for inclusive, community-engaged clinical trials in HIV and other STBBIs.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
The CTN product offering
Product offeringCore offering
The CTN (Canadian HIV Trials Network, also known as CTN+) is a national non-profit research network that designs, coordinates, and conducts clinical trials focused on HIV and other sexually transmitted and blood-borne infections (STBBI). Established in 1990, it operates across five regions of Canada with a National Centre in Montreal and supports researchers, community members, and postdoctoral fellows in advancing prevention, treatment, and care research.
Product overview
The CTN+ is a unified research network platform that provides a comprehensive portfolio of clinical trials research services for HIV and STBBIs across Canada. The core offering consists of clinical trials facilitation services supported by a Research Toolbox for project planning, a Knowledge Mobilization Hub for community engagement and impact evaluation, and a Resource Library for sharing documents and training materials. The Featured Studies Platform enables discovery of specific trials with topic and regional filtering capabilities. Regional Teams across BC & Yukon, Prairies, Ontario, Quebec, and Atlantic regions, along with four Think Tanks (Prevention & Testing, Treatment & Management, Cure & Immunotherapies, and Methods), coordinate activities through this integrated structure.
Differentiator
Problem solved
Functional benefit
Products and services
- HIV and STBBI Clinical Trials Research
Quantifiable outcome
- Successfully secured Phase 2 funding from CIHR Institute of Infection & Immunity
- +1 more outcomes
Companies that use The CTN
Customer profileSegments3 records
Ideal customer profiles3 records
The CTN technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
The CTN partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- MUHC (McGill University Health Centre)coreThe CTN+ National Centre is affiliated with the McGill University Health Centre. National Director Dr. Marina Klein is associated with MUHC, and the network's national operations are headquartered at this institution.
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
The CTN competitors and assessment
Company assessmentBroad incumbents
- amfAR (Foundation for AIDS Research): amfAR is a leading international nonprofit dedicated to HIV/AIDS research funding, advocacy, and cure initiatives. It is a broad incumbent because, like CTN+, it supports HIV research but operates as a grant-maker and convener rather than as a direct clinical trials facilitator.
- IAS (International AIDS Society): IAS is the world's largest association of HIV professionals, convening researchers, clinicians, and policymakers globally. It is a broad incumbent because it operates in the same HIV research ecosystem as CTN+ but on a much wider mandate spanning science, policy, and advocacy rather than direct trial facilitation.
Direct peers
- ACTG (AIDS Clinical Trials Group): ACTG is the world's largest HIV clinical trials network, conducting studies on HIV and its complications across international sites. It is a directly comparable peer because, like CTN+, it is a multi-site HIV clinical trials research network that designs and conducts rigorous therapeutic studies.
- INSIGHT Network: INSIGHT is an international HIV clinical trials network conducting studies on HIV treatment strategies and emerging infectious diseases. It is a direct peer because both networks coordinate multi-center randomized HIV clinical trials and operate with similar governance, statistical, and laboratory infrastructure.
- IMPAACT Network: IMPAACT is an international clinical trials network focused on HIV and related conditions in pregnant people, infants, children, and adolescents. It is a direct peer because it shares CTN+'s mission of running rigorous, multi-site HIV clinical research with community-inclusive design.
- HPTN (HIV Prevention Trials Network): HPTN is a global HIV prevention trials network that develops and tests biomedical and behavioral interventions to prevent HIV transmission. It is a direct peer because both networks run multi-site HIV trials research with structured protocols and community engagement, serving overlapping investigator and sponsor populations.
Others
- CAHR (Canadian Association for HIV Research): CAHR is the Canadian professional association that hosts the annual Canadian Conference on HIV/AIDS Research that CTN+ regularly participates in. It is an adjacent peer because both organizations operate within the Canadian HIV research ecosystem and co-engage investigators, but CAHR is a scientific society rather than a trials network.
- CIHR Institute of Infection and Immunity: CIHR Institute of Infection and Immunity is the Canadian Institutes of Health Research institute that funds CTN+ as its Pan-Canadian Network for HIV and STBBI Clinical Trials Research. It is an ecosystem participant because it is CTN+'s primary sponsor and governance counterpart, directly shaping the network's mandate and funding envelope.
Regional players
- EuroCoord: EuroCoord is a European coordination platform for HIV cohort and clinical research networks. It is a regional peer because it performs a comparable coordinating role for HIV clinical research across European countries, similar to CTN+'s pan-Canadian coordination function.
- ANRS (Agence nationale de recherche sur le sida): ANRS is the French national HIV and STBBI research agency funding clinical trials and cohorts. It is a regional peer because, like CTN+, it operates as a publicly funded national HIV clinical trials network with comparable scope but is anchored in France rather than Canada.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
The CTN social profiles
Digital presenceThe CTN financial estimates
Financial estimateRevenue estimate
Valuation estimate
The CTN leadership team
Management profileNumber of profiles
Profiles3 records
The CTN funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The CTN M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The CTN
What does The CTN do?
The CTN (Canadian HIV Trials Network, also known as CTN+) is a national non-profit research network that designs, coordinates, and conducts clinical trials focused on HIV and other sexually transmitted and blood-borne infections (STBBI). Established in 1990, it operates across five regions of Canada with a National Centre in Montreal and supports researchers, community members, and postdoctoral fellows in advancing prevention, treatment, and care research.
Is The CTN a public or private company?
The CTN is a private company. It is classified as state government owned and is currently operating.
When was The CTN founded?
The CTN was founded in 1990. It employs 101 to 250 people.
Where is The CTN based?
The CTN is headquartered in Vancouver, Canada, in the North America region.
How does The CTN make money?
One revenue line is on record: CIHR Government Funding.
Who are The CTN's main competitors?
Broad incumbents on record are amfAR (Foundation for AIDS Research) and IAS (International AIDS Society). Direct peers are ACTG (AIDS Clinical Trials Group), INSIGHT Network, IMPAACT Network and HPTN (HIV Prevention Trials Network). Others are CAHR (Canadian Association for HIV Research) and CIHR Institute of Infection and Immunity. Regional players are EuroCoord and ANRS (Agence nationale de recherche sur le sida).
Does The CTN have an API?
No public API is recorded for The CTN.
What industry is The CTN in?
The CTN's product category is Clinical Research. Its primary akta.pro industry code is HLACAOAD, Clinical Trial Management Systems (CTMS). Its NAICS code is 5417 and its SIC code is 8000.